Germany and the UK both offer brand owners the means to protect unregistered IP rights. Angela Fox and Michael Nielen of Maucher Jenkins outline the similarities and differences between the rules in the two countries
Trade mark proprietors continue to push the boundaries of protection for non-traditional trade marks. Simon Barker of Freeths explains how their marks can be protected in Europe and the UK
As the UK seeks to forge a new relationship with the EU, Andreas Sætre Hanssen of Onsagers explains how another non-member, Norway, has managed its IP regime
Morten Garberg and Dirk Schüssler-Langeheine of Hoffmann Eitle outline how Europe’s IP regime may look after Brexit and explain what IP owners should be doing to prepare for it
The emergence of big domestic drug companies is reshaping Russia’s pharmaceutical patent landscape. Mikhail Khmara and Yana Lipatova of ARS-Patent explain how originator and generic companies can navigate the country’s changing IP rules
